People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

A Phase IIa clinical trial finds that a single, brief dose of DMT (from ayahuasca) provides rapid and lasting relief for depression.

VANCOUVER, British Columbia, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0 ...

A Canadian-based pharmaceutical company has received approval to conduct a clinical study of the psychedelic compound DMT as a treatment for stroke. Under the plan, pharmaceutical development company ...

‘A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial’ by David Erritzoe et al. was published in Nature Medicine at 16:00 UK time on ...

In a small clinical trial, a single dose of a psychedelic drug paired with psychotherapy produced rapid antidepressant effects that lasted up to three months.

Researchers found that a single 21.5mg dose of DMT reduced depression symptoms compared to placebo in patients with treatment ...

A clinical trial finds that a single dose of the ayahuasca compound DMT produced significant reductions in depressive symptoms ...

People with major depressive disorder saw significant and lasting reductions in their symptoms from a single dose of the psychedelic compound DMT in a ...